|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
956,580,000 |
Market
Cap: |
723.09(B) |
Last
Volume: |
3,201,799 |
Avg
Vol: |
3,291,238 |
52
Week Range: |
$423.21 - $792.28 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 720 |
Guru Rank Value : 1.4 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
656 |
Total Buy Value |
$0 |
$0 |
$0 |
$199,549 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
1 |
Total Shares Sold |
435,750 |
871,420 |
2,951,506 |
6,211,418 |
Total Sell Value |
$330,574,311 |
$608,633,217 |
$2,147,483,647 |
$2,147,483,647 |
Total People Sold |
2 |
2 |
5 |
6 |
Total Sell Transactions |
5 |
14 |
46 |
89 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Lilly Endowment Inc |
10% Owner |
|
2022-07-28 |
4 |
S |
$332.85 |
$29,776,514 |
D/D |
(89,458) |
103,875,441 |
|
-12% |
|
Lilly Endowment Inc |
10% Owner |
|
2022-07-26 |
4 |
S |
$332.52 |
$532,371 |
D/D |
(1,601) |
103,964,899 |
|
-11% |
|
Greene Gabrielle E |
Director |
|
2022-07-18 |
4 |
A |
$321.77 |
$9,975 |
D/D |
31 |
931 |
|
- |
|
Johnson Kimberly H |
Director |
|
2022-07-18 |
4 |
A |
$321.77 |
$9,653 |
D/D |
30 |
1,301 |
|
- |
|
Fyrwald J Erik |
Director |
|
2022-07-18 |
4 |
A |
$321.77 |
$9,975 |
D/D |
31 |
69,528 |
|
- |
|
Alvarez Ralph |
Director |
|
2022-07-18 |
4 |
A |
$321.77 |
$11,262 |
D/D |
35 |
51,735 |
|
- |
|
Luciano Juan R |
Director |
|
2022-07-18 |
4 |
A |
$321.77 |
$14,158 |
D/D |
44 |
13,909 |
|
- |
|
Hedley Mary Lynne |
Director |
|
2022-07-18 |
4 |
A |
$321.77 |
$9,975 |
D/D |
31 |
82 |
|
- |
|
Lilly Endowment Inc |
10% Owner |
|
2022-07-15 |
4 |
S |
$332.60 |
$5,760,013 |
D/D |
(17,310) |
103,966,500 |
|
-10% |
|
Lilly Endowment Inc |
10% Owner |
|
2022-07-06 |
4 |
S |
$329.54 |
$58,539,296 |
D/D |
(177,243) |
103,983,810 |
|
-8% |
|
Lilly Endowment Inc |
10% Owner |
|
2022-06-28 |
4 |
S |
$329.01 |
$296,109 |
D/D |
(900) |
104,161,053 |
|
-15% |
|
Lilly Endowment Inc |
10% Owner |
|
2022-06-27 |
4 |
S |
$329.05 |
$13,772,837 |
D/D |
(41,857) |
104,161,953 |
|
-9% |
|
Lilly Endowment Inc |
10% Owner |
|
2022-06-24 |
4 |
S |
$321.98 |
$69,726,324 |
D/D |
(215,000) |
104,203,810 |
|
-11% |
|
Lilly Endowment Inc |
10% Owner |
|
2022-06-23 |
4 |
S |
$309.23 |
$63,764,750 |
D/D |
(205,000) |
104,418,810 |
|
-14% |
|
Lilly Endowment Inc |
10% Owner |
|
2022-06-22 |
4 |
S |
$305.62 |
$64,435,611 |
D/D |
(210,000) |
104,623,810 |
|
-15% |
|
Fyrwald J Erik |
Director |
|
2022-06-21 |
4 |
A |
$297.34 |
$9,812 |
D/D |
33 |
69,497 |
|
- |
|
Hedley Mary Lynne |
Director |
|
2022-06-21 |
4 |
A |
$297.34 |
$9,812 |
D/D |
33 |
51 |
|
- |
|
Alvarez Ralph |
Director |
|
2022-06-21 |
4 |
A |
$297.34 |
$11,299 |
D/D |
38 |
51,700 |
|
- |
|
Luciano Juan R |
Director |
|
2022-06-21 |
4 |
A |
$297.34 |
$13,975 |
D/D |
47 |
13,865 |
|
- |
|
Greene Gabrielle E |
Director |
|
2022-06-21 |
4 |
A |
$297.34 |
$9,812 |
D/D |
33 |
900 |
|
- |
|
Johnson Kimberly H |
Director |
|
2022-06-21 |
4 |
A |
$297.34 |
$9,812 |
D/D |
33 |
1,271 |
|
- |
|
Zakrowski Donald A |
Chief Accounting Officer |
|
2022-06-01 |
4 |
AS |
$313.44 |
$313,440 |
D/D |
(1,000) |
6,274 |
|
5% |
|
Rau Diogo |
SVP & CIDO |
|
2022-06-01 |
4 |
D |
$313.44 |
$992,351 |
D/D |
(3,166) |
4,394 |
|
- |
|
Rau Diogo |
SVP & CIDO |
|
2022-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,560 |
7,560 |
|
- |
|
Lilly Endowment Inc |
10% Owner |
|
2022-05-27 |
4 |
S |
$314.44 |
$63,796,661 |
D/D |
(200,000) |
104,833,810 |
|
-1% |
|
306 Records found
|
|
Page 6 of 13 |
|
|